Cargando…
Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations
The emergence of antibiotic-resistant S. aureus has become a major public health concern, necessitating the discovery of new antimicrobial compounds. Given that the skin microbiome plays a critical role in the host defence against pathogens, the development of therapies that target the interactions...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295673/ https://www.ncbi.nlm.nih.gov/pubmed/37370267 http://dx.doi.org/10.3390/antibiotics12060947 |
_version_ | 1785063477275000832 |
---|---|
author | Jaumaux, Félix Petit, Kenny Martin, Anandi Rodriguez-Villalobos, Hector Vermeersch, Marjorie Perez-Morga, David Gabant, Philippe |
author_facet | Jaumaux, Félix Petit, Kenny Martin, Anandi Rodriguez-Villalobos, Hector Vermeersch, Marjorie Perez-Morga, David Gabant, Philippe |
author_sort | Jaumaux, Félix |
collection | PubMed |
description | The emergence of antibiotic-resistant S. aureus has become a major public health concern, necessitating the discovery of new antimicrobial compounds. Given that the skin microbiome plays a critical role in the host defence against pathogens, the development of therapies that target the interactions between commensal bacteria and pathogens in the skin microbiome offers a promising approach. Here, we report the discovery of two bacteriocins, cerein 7B and cerein B4080, that selectively inhibit S. aureus without affecting S. epidermidis, a commensal bacterium on the skin. Our study revealed that exposure of S. aureus to these bacteriocins resulted in mutations in the walK/R two-component system, leading to a thickening of the cell wall visible by transmission electron microscopy and subsequent decreased sensitivity to vancomycin. Our findings prompt a nuanced discussion of the potential of those bacteriocins for selective targeting of S. aureus on the skin, given the emergence of resistance and co-resistance with vancomycin. The idea put forward implies that by preserving commensal bacteria, selective compounds could limit the emergence of resistance in pathogenic cells by promoting competition with remaining commensal bacteria, ultimately reducing chronical infections and limiting the spread of antibiotic resistance. |
format | Online Article Text |
id | pubmed-10295673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102956732023-06-28 Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations Jaumaux, Félix Petit, Kenny Martin, Anandi Rodriguez-Villalobos, Hector Vermeersch, Marjorie Perez-Morga, David Gabant, Philippe Antibiotics (Basel) Article The emergence of antibiotic-resistant S. aureus has become a major public health concern, necessitating the discovery of new antimicrobial compounds. Given that the skin microbiome plays a critical role in the host defence against pathogens, the development of therapies that target the interactions between commensal bacteria and pathogens in the skin microbiome offers a promising approach. Here, we report the discovery of two bacteriocins, cerein 7B and cerein B4080, that selectively inhibit S. aureus without affecting S. epidermidis, a commensal bacterium on the skin. Our study revealed that exposure of S. aureus to these bacteriocins resulted in mutations in the walK/R two-component system, leading to a thickening of the cell wall visible by transmission electron microscopy and subsequent decreased sensitivity to vancomycin. Our findings prompt a nuanced discussion of the potential of those bacteriocins for selective targeting of S. aureus on the skin, given the emergence of resistance and co-resistance with vancomycin. The idea put forward implies that by preserving commensal bacteria, selective compounds could limit the emergence of resistance in pathogenic cells by promoting competition with remaining commensal bacteria, ultimately reducing chronical infections and limiting the spread of antibiotic resistance. MDPI 2023-05-23 /pmc/articles/PMC10295673/ /pubmed/37370267 http://dx.doi.org/10.3390/antibiotics12060947 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jaumaux, Félix Petit, Kenny Martin, Anandi Rodriguez-Villalobos, Hector Vermeersch, Marjorie Perez-Morga, David Gabant, Philippe Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title | Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title_full | Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title_fullStr | Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title_full_unstemmed | Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title_short | Selective Bacteriocins: A Promising Treatment for Staphylococcus aureus Skin Infections Reveals Insights into Resistant Mutants, Vancomycin Resistance, and Cell Wall Alterations |
title_sort | selective bacteriocins: a promising treatment for staphylococcus aureus skin infections reveals insights into resistant mutants, vancomycin resistance, and cell wall alterations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295673/ https://www.ncbi.nlm.nih.gov/pubmed/37370267 http://dx.doi.org/10.3390/antibiotics12060947 |
work_keys_str_mv | AT jaumauxfelix selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT petitkenny selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT martinanandi selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT rodriguezvillaloboshector selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT vermeerschmarjorie selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT perezmorgadavid selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations AT gabantphilippe selectivebacteriocinsapromisingtreatmentforstaphylococcusaureusskininfectionsrevealsinsightsintoresistantmutantsvancomycinresistanceandcellwallalterations |